MT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed Hodgkin Lymphoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Autologous Stem Cell Transplant · Classic Hodgkin Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Masonic Cancer Center, Minneapolis, Minnesota, United States
Contact: Study coordinator (Sanjal Desai, MD)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Mecapegfilgrastim With Chemotherapy for Peripheral Blood Stem Cell Mobilization in MM and Lymphoma

Multiple Myeloma · Lymphoma

Abroad (travel likely)RecruitingPHASE2

Hefei, China · Beijing, China

Study to Evaluate the Safety and Efficacy of Daratumumab and Carfilzomib-based Induction/Consolidation/Maintenance Therapy in Transplant-eligible, Ultra High-risk, Newly Diagnosed Multiple Myeloma

Multiple Myeloma · Primary Plasma Cell Leukemia · Extramedullary Multiple Myeloma

Abroad (travel likely)RecruitingPHASE2

Wuhan, China

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer

Metastatic Colorectal Cancer · Metastatic Pancreatic Cancer · Metastatic Ovarian Cancer

Abroad (travel likely)RecruitingPHASE2

Bethesda, United States

Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma

Multiple Myeloma, Newly Diagnosed · Multiple Myeloma (MM)

Abroad (travel likely)RecruitingPHASE2

Birmingham, United States · Denver, United States